- Home
- SPXX vs SMTI Comparison
SPXX vs SMTI Comparison
Compare SPXX & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXX
- SMTI
- Stock Information
- Founded
- SPXX 2004
- SMTI 1982
- Country
- SPXX United States
- SMTI United States
- Employees
- SPXX N/A
- SMTI N/A
- Industry
- SPXX Trusts Except Educational Religious and Charitable
- SMTI Medical/Dental Instruments
- Sector
- SPXX Finance
- SMTI Health Care
- Exchange
- SPXX Nasdaq
- SMTI Nasdaq
- Market Cap
- SPXX 302.8M
- SMTI 288.2M
- IPO Year
- SPXX N/A
- SMTI N/A
- Fundamental
- Price
- SPXX $17.76
- SMTI $34.20
- Analyst Decision
- SPXX
- SMTI Strong Buy
- Analyst Count
- SPXX 0
- SMTI 2
- Target Price
- SPXX N/A
- SMTI $47.00
- AVG Volume (30 Days)
- SPXX 51.3K
- SMTI 31.6K
- Earning Date
- SPXX 01-01-0001
- SMTI 11-12-2024
- Dividend Yield
- SPXX 7.55%
- SMTI N/A
- EPS Growth
- SPXX N/A
- SMTI N/A
- EPS
- SPXX N/A
- SMTI N/A
- Revenue
- SPXX N/A
- SMTI $78,056,873.00
- Revenue This Year
- SPXX N/A
- SMTI $29.95
- Revenue Next Year
- SPXX N/A
- SMTI $19.68
- P/E Ratio
- SPXX N/A
- SMTI N/A
- Revenue Growth
- SPXX N/A
- SMTI 24.66
- 52 Week Low
- SPXX $13.57
- SMTI $26.00
- 52 Week High
- SPXX $16.05
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- SPXX 60.45
- SMTI 47.55
- Support Level
- SPXX $16.89
- SMTI $31.13
- Resistance Level
- SPXX $18.00
- SMTI $35.08
- Average True Range (ATR)
- SPXX 0.21
- SMTI 1.84
- MACD
- SPXX -0.03
- SMTI -0.17
- Stochastic Oscillator
- SPXX 77.93
- SMTI 48.19
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.